THE ROLE OF NEUROTROPHINS AND ANGIOGENIC CYTOKINES IN THE PATHOPHYSIOLOGY OF PERIPHERAL NEUROPATHY IN PATIENTS WITH MULTIPLE MYELOMA

被引:0
|
作者
Luczkowska, K. [1 ]
Litwinska, Z. [1 ]
Pius-Sadowska, E. [1 ]
Sobus, A. [1 ]
Paczkowska, E. [1 ]
Machalinski, B. [1 ]
机构
[1] Pomaranian Med Univ Szczecin, Dept Gen Patol, Szczecin, Poland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PB1937
引用
收藏
页码:773 / 773
页数:1
相关论文
共 50 条
  • [41] Developing a SNP Classifier for Predicting Peripheral Neuropathy by Bortezomib in Multiple Myeloma Patients.
    Kuiper, Rowan
    Corthals, Sophie L.
    Hanifi-Moghaddam, Payman
    de Knegt, Yvonne
    Lokhorst, Henk
    Goldschmidt, Hartmut
    Durie, Brian G. M.
    Van Ness, Brian G.
    Morgan, Gareth J.
    van Duin, Mark
    Avet-Loiseau, Herve
    Sonneveld, Pieter
    BLOOD, 2009, 114 (22) : 715 - 716
  • [42] Nerve conduction study in multiple myeloma patients presenting bortezomib induced peripheral neuropathy
    Pangalis, G. A.
    Zaroulis, C.
    Kyrtsonis, M. C.
    Koutra, E.
    Sachanas, S.
    Anargyrou, K.
    Masouridis, S.
    Galanis, Z.
    Dimou, M.
    Vassilakopoulos, T. P.
    Dimitriadou, E. M.
    Dimopoulou, M. N.
    Kokoris, S. I.
    Siakantaris, M. P.
    Angelopoulou, M. A.
    Panayiotidis, P.
    Matikas, N.
    Pangalis, G. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 256 - 256
  • [43] Improving the assessment of peripheral neuropathy in patients receiving bortezomib (velcade) treatment for multiple myeloma
    O'Hara, K.
    Bloodworth, C.
    Rose, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 : 38 - 38
  • [44] Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients
    Corthals, Sophie L.
    Kuiper, Rowan
    Johnson, David C.
    Sonneveld, Pieter
    Hajek, Roman
    van der Holt, Bronno
    Magrangeas, Florence
    Goldschmidt, Hartmut
    Morgan, Gareth J.
    Avet-Loiseau, Herve
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (11): : 1728 - 1732
  • [45] Peripheral neuropathy in multiple myeloma patients receiving lenalidomide, bortezomib, and dexamethasone (RVD) therapy
    Voorhees, Peter M.
    Laubach, Jacob
    Anderson, Kenneth C.
    Richardson, Paul G.
    BLOOD, 2013, 121 (05) : 858 - 858
  • [46] Chemotherapy-induced peripheral neuropathy in multiple myeloma patients undergoing maintenance therapy
    Shi, Qiuling
    Wang, Xin Shelley
    Reuben, James M.
    Cohen, Evan N.
    Williams, Loretta A.
    Mendoza, Tito R.
    Sailors, Mary L.
    Ilagan, Venus M.
    Cleeland, Charles S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [47] Management of treatment-emergent peripheral neuropathy in multiple myeloma
    P G Richardson
    M Delforge
    M Beksac
    P Wen
    J L Jongen
    O Sezer
    E Terpos
    N Munshi
    A Palumbo
    S V Rajkumar
    J L Harousseau
    P Moreau
    H Avet-Loiseau
    J H Lee
    M Cavo
    G Merlini
    P Voorhees
    W J Chng
    A Mazumder
    S Usmani
    H Einsele
    R Comenzo
    R Orlowski
    D Vesole
    J J Lahuerta
    R Niesvizky
    D Siegel
    M-V Mateos
    M Dimopoulos
    S Lonial
    S Jagannath
    J Bladé
    J San Miguel
    G Morgan
    K C Anderson
    B G M Durie
    P Sonneveld
    Leukemia, 2012, 26 : 595 - 608
  • [48] An observational study assessing peripheral neuropathy related to multiple myeloma
    Leone, C.
    Federico, V.
    La Cesa, S.
    Russo, E.
    Di Stefano, G.
    Finsinger, P.
    Labriola, R.
    Cruccu, G.
    Petrucci, M. T.
    Truini, A.
    NEUROLOGICAL SCIENCES, 2016, 37 (07) : 1141 - 1143
  • [49] TREATABLE BORTEZOMIB-RELATED PERIPHERAL NEUROPATHY IN MULTIPLE MYELOMA
    Koeppen, S.
    Hense, J.
    Nolte, K. W.
    Weis, J.
    Schuler, M.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 : S68 - S68
  • [50] Peripheral neuropathy is not uncommon in untreated multiple myeloma at initial diagnosis
    Malhotra, Pankaj
    Choudhary, Partha Prateem
    Lai, Vivek
    Varma, Subhash
    Varma, Neelam
    Kumari, Savita
    Jain, Sanjay
    Saikia, Biman
    ANNALS OF ONCOLOGY, 2007, 18 : 179 - 179